A detailed history of Bank Of Montreal transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 54,130 shares of LYRA stock, worth $8,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,130
Previous 119,379 54.66%
Holding current value
$8,660
Previous $31,000 64.52%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$0.17 - $0.28 $11,092 - $18,269
-65,249 Reduced 54.66%
54,130 $11,000
Q3 2024

Nov 13, 2024

BUY
$0.24 - $0.34 $28,650 - $40,588
119,379 New
119,379 $31,000
Q1 2024

May 13, 2024

BUY
$4.55 - $6.53 $63,245 - $90,767
13,900 New
13,900 $86,000

Others Institutions Holding LYRA

About Lyra Therapeutics, Inc.


  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.09M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.